Tesla 1st
voted
Last week, the markets were dominated by escalating trade tensions, with tariffs on steel and aluminum imports sparking fears of a global trade war. The European Union retaliated with counter-tariffs on $28 billion worth of U.S. goods, further spooking investors. Meanwhile, concerns over valuations and earnings continued to weigh on the tech sector, with $Adobe (ADBE.US)$ and $Intel (INTC.US)$ making headlines f...



+13
2072
359
23
Tesla 1st
voted
Given the extensive updates and technological innovations expected at NVIDIA's GTC 2025, coupled with historical data suggesting a high likelihood of $NVIDIA (NVDA.US)$'s stock price increasing during such events, a strategic approach to options trading can be particularly beneficial. Here's an integrated strategy that leverages both the expected technological announcements and historical stock performance.
Introduction
$NVIDIA (NVDA.US)$'s premier...



+6
108
23
14
Tesla 1st
liked
Greetings, mooers!
In this special edition, we're excited to bring you the motivating story of @WolfRun, who achieved a remarkable milestone by growing five stocks in his portfolio by tenfold. Don't miss our interactive giveaway at the end of this post!
*Disclaimer: All views expressed in the Mooers' Stories are the independent opinions of WolfRun, which do not reflect the opinions, views, or positions of Moomoo F...
In this special edition, we're excited to bring you the motivating story of @WolfRun, who achieved a remarkable milestone by growing five stocks in his portfolio by tenfold. Don't miss our interactive giveaway at the end of this post!
*Disclaimer: All views expressed in the Mooers' Stories are the independent opinions of WolfRun, which do not reflect the opinions, views, or positions of Moomoo F...



+1
923
344
245
Tesla 1st
commented on
Tesla 1st
commented on
Translated
3
3
$PROCEPT BioRobotics (PRCT.US)$
Which genius is also Bullish on PRCT's Earnings Reports after hours? 🤔🤔🤔
Which genius is also Bullish on PRCT's Earnings Reports after hours? 🤔🤔🤔
Translated
Tesla 1st
Set a live reminder
$NVIDIA (NVDA.US)$
NVIDIA Q4 FY2025 earnings conference call is scheduled for February 26 at 5:00 PM EDT /February 27 at 6:00 AM SGT /February 27 at 9:00 AM AEDT. Subscribe to join the live earnings conference with management NOW!
Beat or Miss?
What do you expect from NVIDIA's Q4 earnings? Will the company beat or miss the estimates? Make sure to click the "Book" button to get what management has to say!
Disclaimer:
This presentation is for information ...
NVIDIA Q4 FY2025 earnings conference call is scheduled for February 26 at 5:00 PM EDT /February 27 at 6:00 AM SGT /February 27 at 9:00 AM AEDT. Subscribe to join the live earnings conference with management NOW!
Beat or Miss?
What do you expect from NVIDIA's Q4 earnings? Will the company beat or miss the estimates? Make sure to click the "Book" button to get what management has to say!
Disclaimer:
This presentation is for information ...

NVIDIA Q4 FY2025 earnings conference call
Feb 27 06:00
1108
573
55
Tesla 1st
commented on and voted
Hi, mooers! 👋
The AI world holds its breath! $NVIDIA (NVDA.US)$ will release its Q4 FY2025 earnings on February 26, just before the market opens. As the AI kingpin faces heightened scrutiny amid market volatility, will it defy expectations again? This is your chance to earn rewards and gain insights by predicting the opening price. Let’s get into it! 🎉
Stay Ahead of the Game
Subscribe to @Moo Live for real-time updates, expert analysis, and t...
The AI world holds its breath! $NVIDIA (NVDA.US)$ will release its Q4 FY2025 earnings on February 26, just before the market opens. As the AI kingpin faces heightened scrutiny amid market volatility, will it defy expectations again? This is your chance to earn rewards and gain insights by predicting the opening price. Let’s get into it! 🎉
Stay Ahead of the Game
Subscribe to @Moo Live for real-time updates, expert analysis, and t...



645
1022
40
$PROCEPT BioRobotics (PRCT.US)$
Procept BioRobotics Corporation (Nasdaq Code: PRCT) is a company focused on developing robotic surgical systems for the treatment of Benign Prostatic Hyperplasia (BPH). Its flagship product, Aquablation, is a minimally invasive procedure designed to provide effective treatment options for BPH patients.
In the last Earnings Reports: In the third quarter of 2024, Procept BioRobotics' sales increased by 66% year-on-year, reaching $58.4 million, exceeding market expectations. Although the company is still operating at a loss, the loss per share has narrowed to $0.40, better than Analyst expectations. Additionally, the company added 45 new Aquablation systems in the USA market, an 18% increase from the previous quarter. Based on these positive performances, the company has raised its full-year sales outlook to between $0.2225 billion and $0.223 billion.
William Blair Analyst Brandon Vazquez holds an optimistic view of Procept BioRobotics, believing that strong market demand, the launch of new products, improved profitability, and increased market penetration are key drivers for the company's future growth. He reiterated a "outperform Large Cap" rating for the company.
Overall, Procept BioRobotics stands out among mid-cap growth stocks, with its innovative...
Procept BioRobotics Corporation (Nasdaq Code: PRCT) is a company focused on developing robotic surgical systems for the treatment of Benign Prostatic Hyperplasia (BPH). Its flagship product, Aquablation, is a minimally invasive procedure designed to provide effective treatment options for BPH patients.
In the last Earnings Reports: In the third quarter of 2024, Procept BioRobotics' sales increased by 66% year-on-year, reaching $58.4 million, exceeding market expectations. Although the company is still operating at a loss, the loss per share has narrowed to $0.40, better than Analyst expectations. Additionally, the company added 45 new Aquablation systems in the USA market, an 18% increase from the previous quarter. Based on these positive performances, the company has raised its full-year sales outlook to between $0.2225 billion and $0.223 billion.
William Blair Analyst Brandon Vazquez holds an optimistic view of Procept BioRobotics, believing that strong market demand, the launch of new products, improved profitability, and increased market penetration are key drivers for the company's future growth. He reiterated a "outperform Large Cap" rating for the company.
Overall, Procept BioRobotics stands out among mid-cap growth stocks, with its innovative...
Translated
$PROCEPT BioRobotics (PRCT.US)$
It was announced today that the financial results for the fourth quarter of 2024 will be released after the market closes on Tuesday, February 25, 2025. The company's management will hold a corresponding conference call starting at 4:30 PM Eastern Time.
Is it time to buy at this price? Waiting for the rush of the Earnings Reports …..🧐🤔
It was announced today that the financial results for the fourth quarter of 2024 will be released after the market closes on Tuesday, February 25, 2025. The company's management will hold a corresponding conference call starting at 4:30 PM Eastern Time.
Is it time to buy at this price? Waiting for the rush of the Earnings Reports …..🧐🤔
Translated